Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Y Warren

Showing results (81-90 of 132) with videos related to

Pageof 14
Sort By:
Oncogene|September 13, 2024
Multifocal, multiphenotypic tumours arising from an MTOR mutation acquired in early embryogenesisClarissa N Pacyna, Madhanagopal Anandapadamanaban, Kevin W Loudon, et al.
Nature Communications|April 28, 2025
Angiogenic and immune predictors of neoadjuvant axitinib response in renal cell carcinoma with venous tumour thrombusRebecca Wray, Hania Paverd, Ines Machado, et al.
NMR in Biomedicine|June 24, 2026
Estimating the Sodium Content: A Case Series of Benign and Malignant Renal Tumours Using <sup>23</sup>Na-MRI at 3 TInes Horvat-Menih, Jonathan R Birchall, Maria J Zamora-Morales, et al.
Virchows Archiv : an International Journal of Pathology|January 6, 2021
Morphological findings in frozen non-neoplastic kidney tissues of patients with kidney cancer from large-scale multicentric studies on renal cancerBehnoush Abedi-Ardekani, Dariush Nasrollahzadeh, Lars Egevad, et al.
Nature Communications|July 16, 2024
Metabolic imaging across scales reveals distinct prostate cancer phenotypesNikita Sushentsev, Gregory Hamm, Lucy Flint, et al.
BMJ Open|October 26, 2024
Multiarm, non-randomised, single-centre feasibility study-investigation of the differential biology between benign and malignant renal masses using advanced magnetic resonance imaging techniques (IBM-Renal): protocolInes Horvat-Menih, Mary A McLean, Maria Jesus Zamora-Morales, et al.
BMC Cancer|November 19, 2021
The WIRE study a phase II, multi-arm, multi-centre, non-randomised window-of-opportunity clinical trial platform using a Bayesian adaptive design for proof-of-mechanism of novel treatment strategies in operable renal cell cancer - a study protocolStephan Ursprung, Helen Mossop, Ferdia A Gallagher, et al.
European Urology|November 18, 2015
The Early Effects of Rapid Androgen Deprivation on Human Prostate CancerGreg L Shaw, Hayley Whitaker, Marie Corcoran, et al.
European Urology Focus|July 30, 2017
DESNT: A Poor Prognosis Category of Human Prostate CancerBogdan-Alexandru Luca, Daniel S Brewer, Dylan R Edwards, et al.
The Journal of Clinical Endocrinology and Metabolism|October 4, 2017
Clinical and Molecular Features of Renal and Pheochromocytoma/Paraganglioma Tumor Association Syndrome (RAPTAS): Case Series and Literature ReviewRuth T Casey, Anne Y Warren, Jose Ezequiel Martin, et al.
Pageof 14

Showing results (81-90 of 132) with videos related to

Sort By:
Pageof 14
Oncogene|September 13, 2024
Multifocal, multiphenotypic tumours arising from an MTOR mutation acquired in early embryogenesisClarissa N Pacyna, Madhanagopal Anandapadamanaban, Kevin W Loudon, et al.
Nature Communications|April 28, 2025
Angiogenic and immune predictors of neoadjuvant axitinib response in renal cell carcinoma with venous tumour thrombusRebecca Wray, Hania Paverd, Ines Machado, et al.
NMR in Biomedicine|June 24, 2026
Estimating the Sodium Content: A Case Series of Benign and Malignant Renal Tumours Using <sup>23</sup>Na-MRI at 3 TInes Horvat-Menih, Jonathan R Birchall, Maria J Zamora-Morales, et al.
Virchows Archiv : an International Journal of Pathology|January 6, 2021
Morphological findings in frozen non-neoplastic kidney tissues of patients with kidney cancer from large-scale multicentric studies on renal cancerBehnoush Abedi-Ardekani, Dariush Nasrollahzadeh, Lars Egevad, et al.
Nature Communications|July 16, 2024
Metabolic imaging across scales reveals distinct prostate cancer phenotypesNikita Sushentsev, Gregory Hamm, Lucy Flint, et al.
BMJ Open|October 26, 2024
Multiarm, non-randomised, single-centre feasibility study-investigation of the differential biology between benign and malignant renal masses using advanced magnetic resonance imaging techniques (IBM-Renal): protocolInes Horvat-Menih, Mary A McLean, Maria Jesus Zamora-Morales, et al.
BMC Cancer|November 19, 2021
The WIRE study a phase II, multi-arm, multi-centre, non-randomised window-of-opportunity clinical trial platform using a Bayesian adaptive design for proof-of-mechanism of novel treatment strategies in operable renal cell cancer - a study protocolStephan Ursprung, Helen Mossop, Ferdia A Gallagher, et al.
European Urology|November 18, 2015
The Early Effects of Rapid Androgen Deprivation on Human Prostate CancerGreg L Shaw, Hayley Whitaker, Marie Corcoran, et al.
European Urology Focus|July 30, 2017
DESNT: A Poor Prognosis Category of Human Prostate CancerBogdan-Alexandru Luca, Daniel S Brewer, Dylan R Edwards, et al.
The Journal of Clinical Endocrinology and Metabolism|October 4, 2017
Clinical and Molecular Features of Renal and Pheochromocytoma/Paraganglioma Tumor Association Syndrome (RAPTAS): Case Series and Literature ReviewRuth T Casey, Anne Y Warren, Jose Ezequiel Martin, et al.
Pageof 14